接受氯萘嗪治疗的患者发生膀胱癌。
Cancer of the bladder in patients treated with chlornaphazine.
作者信息
Laursen B
出版信息
Br Med J. 1970 Sep 19;3(5724):684-5. doi: 10.1136/bmj.3.5724.684.
Abstract
Two patients treated for Hodgkin's disease with chlornaphazine developed cancer of the bladder five and six years after treatment with the drug had been stopped.
摘要
两名接受氯萘嗪治疗霍奇金病的患者在停药五至六年之后患上了膀胱癌。
相似文献
1
Cancer of the bladder in patients treated with chlornaphazine.接受氯萘嗪治疗的患者发生膀胱癌。
Br Med J. 1970 Sep 19;3(5724):684-5. doi: 10.1136/bmj.3.5724.684.
2
[Bladder tumors induced by chlornaphazine treatment].[氯萘嗪治疗诱发的膀胱肿瘤]
Ugeskr Laeger. 1975 Mar 17;137(12):661-6.
3
Bladder tumours induced by chlornaphazine. A five-year follow-up study of chlornaphazine-treated patients with polycythaemia.氯萘嗪诱发的膀胱肿瘤。对接受氯萘嗪治疗的真性红细胞增多症患者的五年随访研究。
Acta Med Scand. 1969 Jan-Feb;185(1-2):133-7.
4
Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
N Engl J Med. 1971 Aug 26;285(9):475-9. doi: 10.1056/NEJM197108262850902.
5
Epidemiological studies of medically used drugs.医用药物的流行病学研究。
Arch Toxicol Suppl. 1980;3:19-25. doi: 10.1007/978-3-642-67389-4_3.
6
Urinary bladder cancer following cyclophosphamide therapy for Hodgkin's disease.环磷酰胺治疗霍奇金病后发生的膀胱癌。
Leuk Lymphoma. 1992 Dec;8(6):503-4. doi: 10.3109/10428199209051035.
7
Vinblastine vs. nitrogen mustard therapy of Hodgkin's disease.
Cancer. 1968 Aug;22(2):473-9. doi: 10.1002/1097-0142(196808)22:2<473::aid-cncr2820220227>3.0.co;2-i.
8
Secondary transitional cell carcinoma and nitrogen mustard treatment.
Urology. 2005 Jun;65(6):1226-7. doi: 10.1016/j.urology.2004.12.037.
9
CHLORNAPHAZIN (ERYSAN) MAY INDUCE CANCER OF THE URINARY BLADDER.氯萘嗪（埃利桑）可能诱发膀胱癌。
Acta Med Scand. 1964 Jul;176:45-50.
10
Leimyosarcoma of the urinary bladder. 13 years after cyclophosphamide therapy for Hodgkin's disease.膀胱平滑肌肉瘤。在接受环磷酰胺治疗霍奇金病13年后发病。
Cancer. 1985 Apr 1;55(7):1597-603. doi: 10.1002/1097-0142(19850401)55:7<1597::aid-cncr2820550731>3.0.co;2-0.
引用本文的文献
1
Genotoxicity Induced by Carcinogenic Agents or Occupational Exposure with Sufficient Evidence for Bladder Cancer.致癌剂或职业暴露诱导的遗传毒性，有充分证据证明与膀胱癌有关。
J Clin Med. 2025 Jun 25;14(13):4492. doi: 10.3390/jcm14134492.
2
Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis.IARC 第一组药物与相关癌症风险：系统评价和荟萃分析。
Sci Rep. 2024 Jan 3;14(1):413. doi: 10.1038/s41598-023-50602-6.
3
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice.膀胱癌流行病学的全球趋势：公共卫生和临床实践面临的挑战。
Nat Rev Clin Oncol. 2023 May;20(5):287-304. doi: 10.1038/s41571-023-00744-3. Epub 2023 Mar 13.
4
Drug-induced bladder and urinary disorders. Incidence, prevention and management.药物性膀胱和泌尿系统疾病。发病率、预防与管理。
Drug Saf. 1998 Jul;19(1):45-55. doi: 10.2165/00002018-199819010-00004.
本文引用的文献
1
Cyclophosphamide and urinary bladder toxicity.环磷酰胺与膀胱毒性。
Cancer Res. 1961 Dec;21:1577-89.
2
The metabolites of 2-naphthylamine produced by rats and rabbits.大鼠和兔子产生的2-萘胺代谢物。
Biochem J. 1955 Mar 19;60(Annual General Meeting):ii-iii.
3
CHLORNAPHAZINE AS A BLADDER CARCINOGEN.
Acta Med Scand. 1964 Jun;175:721-5. doi: 10.1111/j.0954-6820.1964.tb00628.x.
4
A study of the carcinogenic effect of beta-naphthylamine on the normal and substituted isolated sigmoid loop bladder of dogs.β-萘胺对犬正常及取代的离体乙状结肠袢膀胱致癌作用的研究
J Urol. 1953 Dec;70(6):914-25. doi: 10.1016/S0022-5347(17)68005-4.
5
The carcinogenic properties of 2-amino-1-naphthol hydrochloride and its parent amine 2-naphthylamine.盐酸2-氨基-1-萘酚及其母体胺2-萘胺的致癌特性。
Br J Cancer. 1952 Dec;6(4):412-24. doi: 10.1038/bjc.1952.47.
6
Malignant cells in the urine of men exposed to beta-naphthylamine.接触β-萘胺的男性尿液中的恶性细胞。
Can Med Assoc J. 1969 May 17;100(19):879-82.
Zotero 插件